NCT05451212 2025-11-10Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia GravisCabaletta BioPhase 1 Completed7 enrolled
NCT07158892 2025-09-08Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal TestUniversity of Texas at AustinPhase NA Not yet recruiting220 enrolled
NCT06928987 2025-04-15PauseTMInstitut Cancerologie de l'OuestPhase NA Active not recruiting88 enrolled
NCT05355597 2025-04-09"The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors"Atlantic Health SystemPhase 2 Terminated116 enrolled